Overall Survival Improvement in Patients with Lung Cancer and Bone Metastases Treated with Denosumab Versus Zoledronic Acid: Subgroup Analysis from a Randomized Phase 3 Study

查看全文 作　　者：Giorgio;Vittorio;Scagliotti;Vera;Hirsh;Salvatore;Siena;David;H.;Henry;Penella;J.;Woll;Christian;Manegold;Philippe;Solal-Celigny;Gladys;Rodriguez;Maciej;Krzakowski;Nilesh;D.;Mehta;Lara;Lipton;José;Angel;García-Sáenz;José;Rodrigues;Pereira;Kumar;Prabhash;Tu